Etanercept, anticytokines and mania

International Clinical Psychopharmacology

Volumn 20, Issue 4, 2005, Pages 239-241

  Kaufman, Kenneth R ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Affective disorder; Anti cytokine; Anti TNF ; Autoimmune disease; Bipolar disorder; Cycling; Cytokine; Depression; Etanercept; Mania; Psoriasis; TNF

Indexed keywords

ADALIMUMAB; CYTOKINE; ETANERCEPT; HYDROXYCHLOROQUINE; INDOMETACIN; INFLIXIMAB; LAMOTRIGINE; MECLOFENAMIC ACID; METHOTREXATE; OXCARBAZEPINE; RISPERIDONE; SALAZOSULFAPYRIDINE; SERTRALINE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADULT; ARTICLE; BIPOLAR DISORDER; CASE REPORT; COMORBIDITY; CYTOKINE RELEASE; DEPRESSION; DISEASE ASSOCIATION; DISEASE EXACERBATION; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HUMAN; IMMUNOPATHOLOGY; MANIA; MOOD DISORDER; PATHOGENESIS; PRIORITY JOURNAL; PSORIATIC ARTHRITIS;

ADULT; ANTIRHEUMATIC AGENTS; ARTHRITIS, PSORIATIC; BIPOLAR DISORDER; CYTOKINES; FEMALE; HUMANS; IMMUNOGLOBULIN G; RECEPTORS, TUMOR NECROSIS FACTOR;

EID: 21244447421     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-200507000-00008     Document Type: Article

References (39)

1. Anisman H, Merali Z (2003). Cytokines, stress and depressive illness: brain-immune interactions. Ann Med 35:2-11.
2. Boerlin HL, Gitlin MJ, Zoellner LA, Hammen CL (1998). Bipolar depression and antidepressant-induced mania: a naturalistic study. J Clin Psychiatry 59:374-379.
3. Butler DM, Maini RN, Feldmann M, Brennan FM (1995). Modulation of proinflammatory cytokine release in rheumatoid synovial membrane cell cultures. Comparison of monoclonal and TNF-alpha antibody with the interleukin-1 receptor antagonist. Eur Cytokine Netw 6:115-130.
4. Calabrese JR (2004). Depression mood stabilisation: novel concepts and clinical management. Eur Neuropsychopharmacol 14 (suppl 2):S100-S107.
5. Cavaillon JM, Adib-Conquy M, Fitting C, Adrie C, Payen D (2003). Cytokine cascade in sepsis. Scand J Infect Dis 35:535-544.
6. Charles P, Elliott MJ, Davis D, Potter A, Kalden JR, Antoni C, et al. (1999). Regulations of cytokines, cytokine inhibitors, and acute phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis. J Immunol 163:1521-1528.
7. Ghaemi SN, Hsu DJ, Soldani F, Goodwin FK (2003). Antidepressants in bipolar disorder: the case for caution. Bipolar Disord 5:421-433.
8. Ghaemi SN, Rosenquist KJ, Ko JY, Baldassano CF, Kontos NJ, Baldessarini RJ (2004). Antidepressant treatment in bipolar versus unipolar depression. Am J Psychiatry 161:163-1 65.
9. Goldberg JF, Harrow M, Whiteside JE (2001). Risk for bipolar illness in patients initially hospitalized for unipolar depression. Am J Psychiatry 158: 1265-1270.
10. Grippo AJ, Francis J, Weiss RM, Felder RB, Johnson AK (2003). Cytokine mediation of experimental heart failure-induced anhedonia. Am J Physiol Regul Integr Comp Physiol 28:R666-R673.
11. Herman E (2004). Lamotrigine: a depression mood stabilizer. Eur Neuropsychopharmacol 14 (suppl 2):S89-S93.
12. Ichiyama T, Okada K, Lipton JM, Matsubara T, Hayashi T, Furukawa S (2000). Sodium valproate inhibits production of TNF-alpha and IL-6 and activation of NF-kappaB. Brain Res 857:246-251.
13. Ketter TA, Calabrese JR (2002). Stabilization of mood from below versus above baseline in bipolar disorder: a new prospective. J Clin Psychiatry 63, 146-151.
14. Keystone EC, Kavanaugh AF, Sharp JT, Tannenbaum H, Hau Y, Teoh LS, et al. (2004). Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial. Arthritis Rheum 50:1400-1411.
15. Kim YK, Suh IB, Kim H, Han CS, Lim CS, Choi SH, Licinio J (2002). The plasma levels of interleukin-12 in schizophrenia, major depression, and bipolar mania: effects of psychotropic drugs. Mol Psychiatry 7:1107-1114.
16. Kraus MR, Schafer A, Faller H, Csef H, Scheurlen M (2003). Psychiatric symptoms in patients with chronic hepatitis C receiving interferon alfa-2b therapy. J Clin Psychiatry 63:708-714.
17. Kronfol Z, Remick DG (2000). Cytokines and the brain: implications for clinical psychiatry. Am J Psychiatry 157:683-694.
18. Leonardi CL, Powers JL, Matheson RT, Goffe BS, Zitnik R, Wang A, Gottlieb AB, for the Etanercept Psoriasis Study Group (2003). Etanercept as monotherapy in patients with psoriasis. N Engl J Med 349:1987-1990.
19. Maes M, Song C, Lin AH, Pioli R, Kenis G, Kubera M, Bosmans E (1999). In vitro immunoregulatory effects of lithium in healthy volunteers. Psychopharmacology (Berl) 143:401-407.
20. Michalaki V, Syrigos K, Charles P, Waxman J (2004). Serum levels of II-6 and TNF-alpha correlate with clinicopathological features and patient survival in patients with prostate cancer. Br J Cancer 90:2312-2316.
21. Moreland LW, Baugmartner SW, Schiff MH, Tindall EA, Fleischmann RM, Weaver AL, et al. (1997). Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N Engl J Med 337:141-147.
22. Musselman DL, Lawson DH, Gumnick JF, Manatunga AK, Penna S, Goodkin RS, et al. (2001). Paroxetine for the prevention of depression induced by high-dose interferon alpha. N Engl J Med 344:961-966.
23. Patel HC, Boutin H, Allan SM (2003). Interleukin-1 in the brain: mechanisms of action in acute neurodegeneration. Ann NY Acad Sci 992:39-47.
24. Peltola J, Laaksonen J, Haapala AM, Hurme M, Rainesalo S, Keranen T (2002). Indicators of inflammation after recent tonic-clonic epileptic seizures correlate with plasma interleukin-6 levels. Seizure 11:44-46.
25. Penninx BW, Kritchevsky SB, Yaffe K, Newman AB, Simonsick EM, Rubin S, et al. (2003). Inflammatory markers and depressed mood in older persons: results from the Health, Aging and Body Composition study. Biol Psychiatry 54:566-572.
26. Perugi G, Micheli C, Akiskal HS, Madaro D, Socci C, Quilici C, Musetti L (2000). Polarity of the first episode, clinical characteristics, and course of manic depressive illness: a systematic retrospective investigation of 320 Bipolar I patients. Compr Psychiatry 41:13-18.
27. Plata-Salaman CR (2002). Brain cytokines and disease. Acta Neuropsychiatr 14:262-278.
28. Raison CL, Marcin M, Miller AH (2002). Antidepressant treatment of cytokine-induced mood disorders. Acta Neuropsychiatr 14:336-343.
29. Reale M, Iariori C, Gambi F, Feliciani C, Salone A, Toma L, et al. (2004). Treatment with an acetylcholinesterase inhibitor in Alzheimer patients modulates the expression and production of the pro-inflammatory and anti-inflammatory cytokines. J Neuroimmunol 48:162-171.
30. Shandra AA, Godlevsky LS, Vastyanov RS, Oleinik AA, Konovalenko VL, Rapoport EN, Korobka NN (2002). The role of TNF-alpha in amygdala kindled rats. Neurosci Res 42:147-153.
31. Schaefer M, Schwaiger M, Pich M, Lieb K, Heinz A (2003). Neurotransmitter changes by interferon-alpha and therapeutic implications. Pharmacopsychiatry 36 (suppl 3):S203-S206.
32. Schramm TM, Lawford BR, Macdonald GA, Cooksley WG (2000). Sertraline treatment of interferon-alpha-induced depressive disorder. Med J Aust 173:359-361.
33. Taylor PC (2001). Anti-TNF therapy for rheumatoid arthritis and other inflammatory diseases. Mol Biotechnol 19:153-168.
34. Tuglu C, Kara SH, Caliyurt O, Vardar E, Abay E (2003). Increased serum tumor necrosis factor-alpha and treatment response in major depressive disorder. Psychopharmacology (Berl) 170:429-433.
35. Victor FC, Gottlieb AB, Menter A (2003). Changing paradigms in dermatology: tumor necrosis factor alpha (TNF-alpha) blockade in psoriasis and psoriatic arthritis. Clin Dermatol 21:392-397.
36. Waehre T, Yndestad A, Smith C, Haug T, Tunheim SH, Gullestad L, et al. (2004). Increased expression of interleukin-1 in coronary artery disease with downregulation effects of HMG-CoA reductase inhibitors. Circulation 109:1966-1972.
37. Weaver AL (2004). The impact of new biologicals in the treatment of rheumatoid arthritis. Rheumatology (Oxford) 43 (suppl 3):III17-III23.
38. Witkamp R, Monshouwer M (2000). Signal transduction in inflammatory processes, current and future therapeutic targets: a mini review. Vet Q 22:11-16.
39. Wolfe F, Michaud K (2004) Heart failure in rheumatoid arthritis: rates, predictors, and the effect of anti-tumor necrosis factor therapy. Am J Med 116:305-311.